Study #2025-0278
Phase II study of anti-PD-1/VEGF bispecific antibody ivonescimab in patients with previously treated metastatic colorectal cancer
MD Anderson Study Status
Enrolling
Treatment Agent
Ivonescimab
Description
The goal of this clinical research study is to learn if ivonescimab can help to control previously treated, metastatic colorectal cancer.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Metastatic Colorectal Cancer
Study phase:
Phase II
Physician name:
Saurav Haldar
Department:
Gastrointestinal Medical Oncology
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop UT MD Anderson
Show your support for our mission through branded merchandise.